Average premiums and benefits for Medicare's prescription drug program and private Medicare plans are projected to remain stable in 2025 with premiums slightly declining, CMS announced. The premiums are of interest to consumers enrolled in Medicare Advantage plans run by private insurers who are then paid by the government, and the health plans themselves, who set premiums and benefits based on the reimbursement rates. The government has been trying bring down MA prices to the level of original Medicare. Private health insurers had argued cutting their rates would limit what benefits they offer, but the government's projections show they remain stable.
